Merck KGaA (Germany) holds 13 active US FDA Type II Drug Master Files and 8 inactive, has DMF or CEP filings on record for 15 active ingredients, holds 2 active Type IV (excipient) Drug Master Files and is linked to 2 FDA-registered manufacturing sites. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Merck KGaA: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/merck-kgaa

Overview

Merck Serono is the biopharmaceutical business of Merck KGaA, Darmstadt, Germany. It focuses on delivering high-quality medicines in the areas of oncology, neurology, immunology, and endocrinology. As a subsidiary, its mission aligns with the goals of its parent company, Merck KGaA.

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Merck KGaA holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Merck KGaA holds 13 active (21 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • BENZONASE SALT TOLERANTActive2025-04-16
  • BENZONASE SAFETY PLUSActive2023-08-28
  • TRISODIUM CITRATE DIHYDRATEActive2015-12-07
  • UREAActive2015-10-06
  • SODIUM ACETATE TRIHYDRATEActive2010-05-13
  • POTASSIUM IODIDEActive2010-03-09
  • BORIC ACIDActive2009-09-08
  • DIPOTASSIUM HYDROGEN PHOSPHATEActive2006-10-23
  • CALCIUM CHLORIDE DIHYDRATEActive2005-07-01
  • MAGNESIUM CHLORIDE HEXAHYDRATEActive2004-11-16
  • SODIUM FLUORIDEActive1991-08-07
  • PRAZIQUANTEL 2-(CYCLOHEXYLCARBONYL)-1,2,3,6,7,11BETA-4HPYRAZINO-(2,1-ALPHA)Active1981-10-02
  • MEGLUMINEActive1978-10-17
  • SODIUM ACETATE ANHYDROUSInactive2017-10-10
  • SAFINAMIDE METHANESULFONATEInactive2014-06-12
  • EMD 68 843Inactive2000-11-15
  • EMD 121974Inactive1999-08-04
  • BISOPROLOL FUMARATE 2:1Inactive1989-04-12
  • TITRIPLEX VS, DIETHYLENETRIAMINEPENTAACETIC ACIDInactive1986-06-12
  • MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN ALCALA, SPAIN.Inactive1984-03-19
  • MANNITOL, PYROGENE-FREEInactive1978-12-06

Excipient Drug Master Files

Merck KGaA holds 2 active (2 total) FDA Type IV Drug Master Files. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.

  • POLYVINYL ALCOHOL 3-82Active2023-11-21
  • ALC-0315Active2023-08-07

Registered manufacturing sites (2)

Physical sites registered with the US FDA and resolved to Merck KGaA, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Merck KGaA in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Merck KGaA?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.